Pharmacokinetic Study of Posaconazole Boosted Fosamprenavir.
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 28 Jul 2010
At a glance
- Drugs Fosamprenavir; Posaconazole; Ritonavir
- Indications HIV infections
- Focus Pharmacokinetics
- Acronyms EPOS
- 28 Jul 2010 Results have been published in the Journal of Antimicrobial Chemotherapy.
- 19 Feb 2010 Results presented at the 17th Conference on Retroviruses and Opportunistic Infections (CROI).
- 09 Dec 2009 Status changed from completed to active, no longer recruiting as reported by ClinicalTrials.gov.